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Abstract
Background: Acute management of traumatic brain injury (TBI), in particular mild TBI, focuses on the detection of
the 5–7 % who may be harboring potentially life-threatening intracranial hemorrhage (IH) using CT scanning.
Guidelines intending to reduce unnecessary head CT scans using available clinical variables to detect those at
high IH risk have shown varying results. Recently, the Scandinavian Neurotrauma Committee (SNC) derived a
new set of high-IH risk variables for adults with TBI using an evidence-based literature review. Unlike previous
guidelines, the SNC guideline incorporates serum values of the brain protein S100B with clinical variables.
Methods: We performed a nested cohort study of adults with mild TBI presenting to six emergency departments
in New York and Pennsylvania within 6 h of injury. Patients were managed according to existing guidelines for CT
selection. All patients underwent head CT scanning and serum S100B measurement, as well as prospective collection
of clinical variables, as a requirement of the parent study. Using the SNC guidelines, S100B values and clinical variables
were applied to these subjects, classifying each into one of five pre-defined severity categories, as well as predicting
the need for head CT scanning to identify IH. This classification was then compared to actual head CT results to
determine guideline sensitivity and specificity.
Results: In total, 662 adults (mean age 42 years, range 18–96; 258 females, 549 Caucasians) were available for analysis;
36 (5 %) had IH on head CT scan. The SNC guidelines had a sensitivity of 97 % (95 % CI, 84–100 %) and a specificity of
34 % (95 % CI, 30–37 %) for the detection of IH on head CT. Application of the SNC guidelines would have resulted in
a CT reduction of 32 % (211/662 patients). One patient with low-risk mild TBI and a S100B level under 0.10 μg/L had a
traumatic CT abnormality and would have been discharged with strict adherence to the guidelines. However, this
patient did not need any intervention for the injury and had a good outcome.
Conclusion: Using the SNC guideline could save approximately one third of CT scans in a pre-selected cohort of mild
TBI patients with little or no impact on patient outcome.
Keywords: Biomarkers, Brain injury, Computed tomography, Decision rule, Guidelines, Head injury, Management, Mild
traumatic brain injury, S100B/S100/S100BB, Traumatic brain injury
* Correspondence: dr.johan.unden@gmail.com
3Department of Intensive Care and Perioperative Medicine, Lund University,
20502 Malmo, Sweden
Full list of author information is available at the end of the article
© 2015 Undén et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Undén et al. BMC Medicine  (2015) 13:292 
DOI 10.1186/s12916-015-0533-y
Background
Traumatic brain injury (TBI) is a leading cause of mortality
and morbidity [1], and one of the most common reasons to
seek emergency department (ED) care [2, 3]. The vast ma-
jority of patients with acute (<24 h after injury) TBI are
conscious on ED arrival with a Glasgow Come Scale (GCS)
of 13–15. These patients are typically defined as mild TBI
(mTBI) and constitute approximately 95 % of all TBIs [4].
Although conscious on arrival, a small portion of these pa-
tients will have traumatic intracranial findings on computed
tomography (CT) and some will require neurosurgical
intervention [5]. Many of these are therefore subjected to
CT scanning, hospital admission or both. Considering the
economic implications of CT scanning and hospital ad-
mission, coupled with escalating concerns for radiation
risks from CT scans [6, 7], several guidelines and decision
rules have been published aiming to guide ED physicians to
minimize unnecessary CT scans and/or admission while
ensuring a safe triage for mTBI patients [8, 5]. Some of
these have been externally validated with varying results
[9–11]. Unfortunately, these guidelines are generally not ap-
plicable to all mTBI patients presenting in a typical ED.
Further, there are concerns that introduction of new guide-
lines may actually lead to an increase in CT scans [12].
Recently, attention has been focused on efforts using
brain-specific biomarkers, mainly protein S100B, in an
attempt to reduce unnecessary CT scanning following
mTBI [13, 14]. S100B is a dimeric astroglial protein of
approximately 21 kD. Although the specific function of
the protein has not been established, it seems to have
both intracellular and extracellular effects [15]. The half-
life of S100B is short, with recent data suggesting a half-
life of less than 30 min [16]. Although first thought to
be brain specific, studies have shown that low levels of
S100B exist in extracerebral tissues and may limit the
clinical specificity of S100B in TBI management [17].
Despite this, the high sensitivity and clinical negative
predictive value of S100B justifies the use of the protein
in TBI management. However, since much of the clinical
evidence concerning S100B is relatively recent, it has
not been included in clinical guidelines but is neverthe-
less used clinically in many European countries [18].
In 2013, the Scandinavian Neurotrauma Committee
(SNC) published evidence-based guidelines for initial
management of TBI for adults [19] (Fig. 1). These guide-
lines are designed for patients with acute (<24 h from in-
jury) TBI and for detection of important intracranial
injuries, such as those needing neurosurgical intervention
and/or intensive care support. The classification of mTBI
has further been divided into high, medium and low
risk depending on the presence of certain risk factors.
The guidelines also include biomarker S100B as a clin-
ical tool for reducing CT scans in a subset of mTBI pa-
tients. Although these guidelines were designed for the
Scandinavian healthcare systems, validation in an external
cohort would be of interest.
Methods
We performed a retrospective nested cohort study of
adults with mTBI presenting to the ED within 6 h of in-
jury. The parent study was a prospective, multicenter,
cohort study designed to determine the classification ac-
curacy of serum S100B, serum apolipoprotein A1, and
clinical variables for identifying patients with mild TBI
and for identifying patients with traumatic abnormalities
on head CT [14]. Given the similarities between the vari-
ables collected and the variables contained in the SNC,
these data permitted an assessment of the performance
of the SNC.
Participants were enrolled in the parent study at five
hospitals in Upstate New York and one hospital in
Pennsylvania between 2008 and 2010. Subjects were
eligible for inclusion in the parent study if they were
aged 1 year or older, had mTBI as defined by the Centers
for Disease Control and Prevention’s National Center for
Injury Prevention and Control (a blow to the head or rapid
acceleration/deceleration resulting in at least one of the
following: a loss of consciousness (LOC) ≤30 min, post-
traumatic amnesia ≤24 h, neuropsychological abnormality
[any transient period of confusion, disorientation, or
impaired consciousness; in children ≤2 years old: irritabil-
ity, lethargy, or vomiting post-injury], or neurological
abnormality [seizure acutely following injury, hemiplegia,
or diplopia]) [1]. An additional inclusion criteria was the
availability of head CT scanning as part of their clinical
care. The Institutional Review Boards for each of the six
participating centers approved this study and the process
of informed consent. All participants (or guardians of par-
ticipants) gave informed consent.
Participants
Subjects were selected from the parent study into this
nested cohort if they were adults ≥18 years of age (the SNC
guidelines are designed and intended for adults) and had
sufficient data present in order to classify patients according
to the guidelines.
Clinically-relevant variables
Subjects participating in the parent cohort were inter-
viewed in the ED by trained research assistants for injury
mechanism, initial symptoms, demographics, and medical
history. The emergency provider was also interviewed and
the emergency chart was reviewed to determine physical
exam signs, associated injuries, and GCS score. The deci-
sion to collect specific clinical variables was based on their
inclusion in two head CT clinical decision rules that were
in use at the time the parent study was conducted, namely
the New Orleans Criteria (NOC) [8] and the Canadian CT
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Head Rule [5]. The SNC Head CT guideline, which was
published after the parent study was completed, recom-
mended a slightly different set of clinical variables [19].
The subset of clinical variables collected in the parent
study that were identical or similar to the variables in the
SNC head CT guideline were analyzed in the nested co-
hort. The extent to which this subset of clinical variables
overlap with the variables recommended by the SNC head
CT guideline is shown in Table 1.
As the variables collected in the parent study were not
chosen with the SNC guidelines in mind, certain assump-
tions were made a priori. As double vision and paralysis
were the only neurologically specific symptoms recorded,
these were composited to the variable of focal neurological
deficit. Further, suspected/confirmed LOC from the guide-
lines was equated with unsure/confirmed LOC from the
cohort data. Significant extracerebral injury was met if in-
ternal organ injury, fractures and blast/burn/electrocution
injuries were noted. Minor injuries, such as lacerations
and bruises, were not classified as significant extracerebral
injuries.
Head CT scans
At each study site, head CT scans were interpreted by
board-certified radiologists who were blinded to the labora-
tory results. The final reading entered into the radiology
Fig. 1 Scandinavian Neurotrauma Committee guidelines [19]
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image database at each institution was used to determine
the presence or absence of intracranial abnormalities. Trau-
matic CT abnormalities were defined as subdural hema-
tomas, epidural hematomas, subarachnoid hemorrhage,
edema, skull fracture, and cerebral contusions.
Blood draw and sample handling
Blood for S100B sampling was drawn from mTBI sub-
jects within 6 h of the time of injury. Four milliliters of
whole blood was drawn into a serum separator tube and
immediately placed on ice. Within 60 min, the blood
was centrifuged at 3000 rpms for 10 min and the serum
was aliquoted into 500 μL tubes frozen at −80 °C.
S100B assay
Serum S100B concentrations were determined by a fully
automatic electrochemoluminometric immunoassay (Elecsys
S100; Roche Diagnostics, Penzberg, Germany) with a detec-
tion limit of 0.005–39 lg/L. The analyte was sandwiched
between two monoclonal antibodies directed against
the beta-chain of the S100 dimer. Then, streptavidin-
coated microparticles were added and the immunocom-
plex was bound to the solid phase. In the measurement
cell, unbound components were removed and a defined
voltage used to initiate the electrochemiluminescent re-
action. The resultant light emission was then measured
using a photomultiplier. S100B assays were performed
from November to December 2010. Resulting S100B
values were not available to the emergency physicians
caring for the subjects involved in this study, nor where
they available to interviewers and trained research assis-
tants. Thus, providers and research personnel were blinded
to S100B results.
Outcome
One month after the initial ED visit, outcome was deter-
mined by telephone interview using the Rivermead Post
Concussion Questionnaire [20, 21]. Subjects were asked
to rate the severity of 16 post-concussive symptoms
(such as headache), compared to pre-injury, on a Likert
scale ranging from “0” (absent) to “4” (severe). Total
scores thus ranged from 0–64. The interviewer was
blinded to the details of the ED visit.
Analysis
Using the SNC guidelines, S100B values and clinical var-
iables were used to classify each subject into one of the
five SNC-defined head injury severity categories (moderate
TBI, mTBI/high risk, mTBI/medium risk, mTBI/low risk,
and minimal TBI). In order to estimate the ability of the
SNC to determine head injury severity, the prevalence of
traumatic CT abnormalities in each severity category was
calculated and compared. Because the number of CT+
subjects was ≤5 in two severity groups (moderate-risk and
medium-risk mTBI), the Fishers exact test, rather than the
χ2 test, was used to make these comparisons. Given the
fixed samples sizes of each SNC severity group and the
number of CT+ subjects in each group, the power to de-
tect the observed differences in CT+ prevalence between
groups – assuming a Type 1 error rate of 0.05 – ranged
from 0.132 to 0.717. The need for head CT scanning
as predicted by the SNC was then compared to actual
head CT results to determine guideline sensitivity and
specificity.
Results
During the study period, 784 subjects with mTBI were
enrolled into the parent study; 93 were children and
therefore not considered for the guidelines. In 29 pa-
tients, vital data was missing (mainly GCS scores), which
made it impossible to accurately classify the patients and
they were therefore excluded. Thus, 662 patients were
eligible for analysis (Fig. 2). Most subjects in the nested
cohort were Caucasian and male (Table 2).
SNC guidelines and head injury severity
CT scans were positive (CT+) for traumatic abnormal-
ities in 36/662 patients (5 %). Eight patients showed
cerebral contusions, six had traumatic subarachnoid
hemorrhage, four had subdural hematomas, two had
petechial hemorrhage/shear injury, one had cerebral
edema, one had a linear skull fracture, and one had an
epidural hematoma. The remaining 13 patients had a
combination of intracranial traumatic abnormalities. No
Table 1 Comparison of clinical variables collected and those
included in SNC guideline
Clinical variables collected SNC head CT guideline [19]
Post-traumatic seizure Post-traumatic seizure
Age Age ≥65 years
Vomiting, number of times Vomiting ≥2 times
Glasgow Coma Scale score Glasgow Coma Scale score
Suspected open skull fracture Clinical signs of depressed
skull fracture
Signs of basilar skull fracture Clinical signs of basilar skull
fracture
Diplopia, paralysis Focal neurologic deficit
All current neurologic conditions,
including hydrocephalus
Shunt-treated hydrocephalus
prothrombin ratio and international
normalized ratio, not collected
Coagulation disorders




Loss of consciousness Suspected or confirmed loss
of consciousness
All extracranial injuries Significant extracerebral injury
S100B levels S100B ≤0.10 μg/L
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patients in the cohort needed neurosurgical intervention
and none died as a result of the TBI.
Eight subjects were classified by SNC as moderate
TBI, 119 as high-risk mTBI, 12 as medium-risk mTBI,
430 as low-risk mTBI, and 93 as minimal TBI (Table 3).
The prevalence of CT+ was highest in the moderate TBI
group (25 %) and lowest in the minimal TBI group
(0 %). Compared to the minimal TBI group, the CT+
prevalence was significantly higher in the moderate TBI
(P = 0.006), in the high-risk mTBI group (P = 0.003), in
the medium-risk mTBI group (P = 0.012), and in low-
risk mTBI group (P = 0.021; Fig. 3). The CT+ prevalence
in the moderate TBI group (25 %) was higher than the
low-risk mTBI group (5 %), but this difference did not
reach statistical significance. The CT+ prevalence in the
medium-risk mTBI (17 %) was higher than that of the
high-risk mTBI (8 %), but this difference did not reach
statistical significance.
SNC guidelines and prediction of traumatic abnormalities
on head CT
The SNC guidelines classified 451 subjects as needing a
head CT scan, and 211 as not needing one. The SNC
guidelines had a sensitivity of 97 % (95 % CI, 84–100 %)
Fig. 2 Study flow chart
Table 2 Characteristics of the nested cohort
Variable
Age, mean (range) 42 (18–96) years
Sex, percentage female 39 %
Race 83 % Caucasian
Head CT results 37 CT+ (6 %)
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and a specificity of 34 % (95 % CI, 30–37 %) for predict-
ing traumatic CT abnormalities (Table 3).
In patients with high-risk mTBI, 84 patients exhibited
double vision as a risk factor and four of these had CT+
findings. Of 19 patients with paralysis, none had a CT+
lesion. Of 18 patients with seizures and 12 patients with
clinical suspicion of open/depressed skull fracture, two
cases in each showed CT+ findings. Finally, eight pa-
tients with anticoagulant use and six patients with clin-
ical signs of basal skull fractures each showed one case
of CT+. Overall, 430 patients were classed as low-risk
mTBI (65 % of the total sample). Of these, 340 were
eligible for S100B sampling according to the SNC
guidelines (10 underwent sampling more than 6 h after
injury and 80 patients had significant extracerebral in-
juries). Of these, 118 had levels <0.10 μg/L and 222 had
levels ≥0.10 μg/L (35 % below cut-off ). In patients with
extracerebral injury, six had CT+ and all of these had
elevated S100B levels. None of the 10 patients with
sampling done after 6 h from injury had CT+ results.
In total, application of the SNC guidelines to this val-
idation sample would have resulted in a CT reduction of
32 % (211/662 patients); one patient with a low-risk mild
TBI and a S100B level under 0.10 μg/L had a traumatic
CT abnormality. This patient was a 20-year-old male
presenting at the ED after a motor vehicle accident
(without ejection) with a GCS of 14 and LOC (unclear
time period). CT showed a small cerebral contusion
which subsided on follow-up CT scans (Fig. 4). He was
discharged home from the inpatient unit without needing
medical or surgical intervention for his injury and had a
good neurological outcome on follow-up. His total River-
mead Post Concussion Questionnaire score was low (11
out of 64) and he had new symptoms of moderate fatigue
and mild issues of frustration and poor memory.
Discussion
In response to escalating healthcare costs, care providers
have a responsibility to manage patients within health-
economic considerations [22]. TBI, in particular mTBI,
represents a significant burden for hospitals and ED
facilities in developed countries. Existing guidelines for
management of such patients differ in sensitivity and spe-
cificity with respect to detection of CT findings, traumatic
CT findings, clinically important CT findings and need
for neurosurgical/intensive care intervention [9, 11].
The SNC guideline offers a comprehensive aid to manage-
ment of all adults with TBI and includes CT management
options.
The results indicate that the SNC guidelines seem to
predict TBI severity within a cohort of patients with
GCS 13–15. The CT+ prevalence in the minimal TBI
group was significantly lower than each of the other
four severity groups. In addition, the CT+ prevalence
in the moderate TBI group was five times higher than
that of the low-risk mTBI group, but this difference
was not statistically significant, likely due to the small
number of subjects (n = 8) in the moderate risk group.
Counterintuitively, the CT+ prevalence in the medium-
risk mTBI group was over twice that of the high-risk
mTBI group, but this difference was also not statistically
significant, likely due to the small number of subjects
(n = 12) in the medium-risk mTBI group.
Adherence to the SNC guidelines would have resulted in
a 32 % reduction in CT scans in the present population – a
population clinically judged to need a CT scan according to
Table 3 Performance of SNC guideline in validation cohort
CT results
+ − Total
SNC guideline CT 35 416 451
No CT 1 210 211
Total 36 626 662
Overall, a 32 % reduction in CT scanning was observed if SNC guidelines were
used; 1 missed patient (low-risk mild with S100B ≤0.10 μg/L), see text for details;
Prevalence of CT findings: 5 %; Sensitivity: 97 % (95 % CI, 84–100 %); Specificity:
34 % (95 % CI, 30–37 %); Negative predictive value, 100 % (95 % CI, 97–100 %);
Positive predictive value, 8 % (95 % CI, 6–11 %)
Fig. 3 Prevalence of traumatic CT abnormalities by SNC guideline
severity categories. *P <0.01, **P = 0.01–0.05
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local routines. Since many of these patients were also ad-
mitted to hospital, the cost saving potential is substantial.
However, one patient, who was classified by the SNC guide-
line as low-risk mTBI and had a low S100B level (0.09 μg/
L, just below cut-off), showed a traumatic abnormality on
CT scanning. The finding was relatively minor (small con-
tusion) and did not need any specific treatment. Missing
this CT abnormality would therefore not have had an
impact on the care and outcome of this patient. S100B is
not 100 % sensitive and less significant, non-neurosurgical
lesions, such as the lesion in this study, may be missed
using the present cut-off [23, 24]. Additionally, the SNC
guidelines were designed to primarily detect patients
needing neurosurgical or other specific intervention,
with traumatic CT abnormalities being a secondary, yet
important, goal [19]. It is likely that the difference in
medico-legal attitudes between countries may influence
the view on this matter. In Scandinavia, missing un-
complicated intracranial complications that do not need
specific intervention in patients with good outcome is
acceptable, especially if this implies resource saving.
However, this may not be true for other countries such
as the United States and Canada.
Since S100B is currently unavailable in the US, the
management according to the SNC guidelines would
have differed in that patients with low-risk mTBI would
have had a CT scan. In this scenario, no patients would
have been missed but the CT use would have been reduced
to 14 % (93/662).
S100B is included as an option in the guidelines for
those centers with the ability to perform 24/7 real-time
analysis. As most Scandinavian centers have this possibility,
S100B is now widely used in this setting. Published reports
of S100B in clinical use [18] and unpublished summaries
of current use with the new guidelines have shown very
promising results. However, these recent observations
need to be scientifically examined, a process which is
currently underway via a validation study in Scandinavia.
Further, the practicality of using the SNC guidelines would
be of interest but could not be examined in the present
study. A guideline would have to be practically viable for
the treating of professionals in order for such a tool to be
clinically useful.
The sensitivity and specificity figures reported here are
not reflective of an unselected cohort of TBI patients, but
rather a selection of patients where current guidelines
advocate a CT scan. In a more unselected cohort, the
sensitivity and negative predictive ability would reasonably
be higher as the present study had already selected a
population with a higher risk for CT abnormalities (higher
pre-test probability). Therefore, it is also difficult to
compare the performance of different guidelines as the
cohort is pre-selected. The NOC criteria, for example,
would reasonably advocate CT scans on many patients
not considered for inclusion into this cohort and can
only be used on the subset of patients with GCS 15.
Additionally, both the NOC and Canadian CT Head
Rule criteria can only be applied to patients with specific
symptoms (LOC and LOC, amnesia or confusion, respect-
ively), unlike the SNC guidelines, which are designed for all
adult patients following a non-severe TBI. The only correct
method of comparing these guidelines would be in an unse-
lected series of all TBI patients presenting at the ED.
Limitations
The S100B cutoff used in the SNC guidelines was derived
from studies involving mostly Caucasian populations. This
cutoff might not perform the same in subjects of color,
such as some of those in the current study. However, this
would rather affect the specificity of S100B (i.e. more false
Fig. 4 False negative subject. A 20-year-old with GCS 14 and unclear episode of loss of consciousness. The patient would be classed as low-risk
mild traumatic brain injury and had a S100B of 0.09 μg/L. CT shows a small contusion and extracranial soft tissue swelling. The contusion subsided
on follow-up CT after 25 days. The patient did not need any intervention or treatment and was discharged from the inpatient unit with a good
neurological outcome
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positives) and therefore theoretically reduce the CT saving
ability of S100B in non-Caucasian populations. S100B as a
single test had a 35 % CT reduction ability in this study,
which is similar to other cohorts [25].
Although the reported cohort is relatively large, the
absolute number of CT+ patients was small and no patients
needed neurosurgical or specific medical intervention. A
much larger cohort would be necessary to fully examine
these aspects. Further, although the original patient inclu-
sion was prospective, the validation of the SNC guidelines
was retrospective. A purpose-designed prospective study is
recommended and currently underway.
Conclusion
The updated SNC guidelines can accurately classify injury
severity and may further reduce CT scans in a selected
population of patients with TBI requiring CT scanning.
The one patient missed by the guidelines did not require
any intervention and had a good outcome.
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